Yang Zhao is a Senior Principal Scientist at Boehringer Ingelheims Cancer Immunology Therapeutic Area, with a Ph. D. from the University of Michigan. He has a demonstrated history of leading drug discovery and early-phase development in oncology and immunology since 2007 at companies like Janssen and Eli Lilly.
Based on his shared content, Yang is deeply immersed in scientific advancement, frequently posting about cutting-edge research like CRISPR screens, cellular biology, and new therapeutic modalities. He appears driven by a problem-solving mindset, stating that being "solution oriented is the key, " and is keen on developing new talent.
He has served as a co-lead for the Clinical Development Teams for major drugs Simponi and Remicade.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.